1. Home
  2. VOC vs SCLX Comparison

VOC vs SCLX Comparison

Compare VOC & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VOC

VOC Energy Trust Units of Beneficial Interest

HOLD

Current Price

$3.32

Market Cap

57.5M

Sector

Energy

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$5.40

Market Cap

55.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VOC
SCLX
Founded
2010
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.5M
55.1M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
VOC
SCLX
Price
$3.32
$5.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
87.9K
36.4K
Earning Date
01-01-0001
04-10-2026
Dividend Yield
12.46%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$30,253,000.00
Revenue This Year
N/A
$122.52
Revenue Next Year
N/A
$186.30
P/E Ratio
$6.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.63
$4.20
52 Week High
$3.84
$34.27

Technical Indicators

Market Signals
Indicator
VOC
SCLX
Relative Strength Index (RSI) 55.09 33.00
Support Level $3.30 $4.20
Resistance Level $3.54 $7.77
Average True Range (ATR) 0.08 0.36
MACD -0.00 0.02
Stochastic Oscillator 59.28 12.80

Price Performance

Historical Comparison
VOC
SCLX

About VOC VOC Energy Trust Units of Beneficial Interest

VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust. It operates in a single operating and reportable segment.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: